Human Neurotrimin Antibody
R&D Systems, part of Bio-Techne | Catalog # AF1235
Key Product Details
Species Reactivity
Validated:
Human
Cited:
Rat
Applications
Validated:
Immunohistochemistry, Western Blot
Cited:
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human Neurotrimin
Val31-Asn321
Accession # Q9P121
Val31-Asn321
Accession # Q9P121
Specificity
Detects human Neurotrimin in direct ELISAs and Western blots.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for Human Neurotrimin Antibody
Application
Recommended Usage
Immunohistochemistry
5-15 µg/mL
Sample: Immersion fixed paraffin-embedded sections of human dorsal root ganglia and spinal cord
Sample: Immersion fixed paraffin-embedded sections of human dorsal root ganglia and spinal cord
Western Blot
0.1 µg/mL
Sample: Recombinant Human Neurotrimin
Sample: Recombinant Human Neurotrimin
Reviewed Applications
Read 2 reviews rated 5 using AF1235 in the following applications:
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Neurotrimin
Additional Neurotrimin Products
Product Documents for Human Neurotrimin Antibody
Product Specific Notices for Human Neurotrimin Antibody
For research use only
Loading...
Loading...
Loading...
Loading...